Skip to main content

BioDiscovery and Empire Genomics to Integrate, Co-Market aCGH Tech and Related Software

NEW YORK (GenomeWeb News) — Empire Genomics and BioDiscovery will integrate and co-market certain of their products for the array comparative genomic hybridization market, BioDiscovery said Wednesday. 
 
Empire Genomics, a Buffalo, NY-based start-up, specializes in molecular karyotyping technology in an aCGH platform that is used to quantify “changes in chromosomal abnormalities,” BioDisovery said.
 
BioDiscovery will provide image and aCGH software to the partnership.
 
Financial terms of the deal were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.